Cholecalciferol supplementation effectively improved tertiary hyperparathyroidism, FGF23 resistance and lowered coronary calcification score: a prospective study.

Hu, Shu-Meng; Bai, Yang-Juan; Li, Ya-Mei; Tao, Ye; Wang, Xian-Ding; Lin, Tao; Wang, Lan-Lan; Shi, Yun-Ying

Hu, Shu-Meng; Bai, Yang-Juan; Li, Ya-Mei; Tao, Ye; Wang, Xian-Ding; Lin, Tao; Wang, Lan-Lan; Shi, Yun-Ying.

Afiliação

Hu SM; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Bai YJ; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li YM; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tao Y; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang XD; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lin T; Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang LL; Department of Laboratory Medicine/Research Centre of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shi YY; Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Endocr Connect ; 11(8)2022 Aug 01.

Article em En | MEDLINE | ID: mdl-35904219

Palavras-chave

alpha Klotho; coronary calcification; fibroblast growth factor 23; kidney transplantation; secondary hyperparathyroidism; vitamin D

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google